Humacyte, Inc.
NASDAQ:HUMA
1.41 (USD) • At close May 1, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 44.937 | 80.448 | 149.772 | 217.502 | 39.929 | 93.713 |
| Short Term Investments
| 0 | 0 | 2.107 | 8 | 0 | 0 |
| Cash and Short Term Investments
| 44.937 | 80.448 | 151.879 | 225.502 | 39.929 | 93.713 |
| Net Receivables
| 0 | 0 | 0.031 | 0.176 | 0.113 | 0.601 |
| Inventory
| 0 | 0 | -0.031 | 0 | 0 | 0 |
| Other Current Assets
| 2.922 | 2.83 | 4.596 | 3.662 | 1.407 | 0.64 |
| Total Current Assets
| 47.859 | 83.278 | 154.208 | 229.34 | 41.449 | 94.954 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 38.553 | 44.945 | 50.094 | 57.193 | 65.239 | 73.737 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 51.46 | 0 | -50.094 | -57.193 | -65.239 | -73.737 |
| Total Non-Current Assets
| 90.013 | 44.945 | 50.094 | 57.193 | 65.239 | 73.737 |
| Total Assets
| 137.872 | 128.223 | 204.302 | 286.533 | 106.688 | 168.691 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 4.49 | 6.49 | 1.595 | 2.094 | 2.274 | 3.272 |
| Short Term Debt
| 0 | 2.613 | 10.877 | 2.026 | 4.222 | 1.57 |
| Tax Payables
| 0 | 0 | 0 | 0.173 | 0.145 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 4.731 | 0 | 0 |
| Other Current Liabilities
| 15.464 | 9.34 | 7.108 | 6.757 | 4.592 | 6 |
| Total Current Liabilities
| 19.954 | 18.443 | 19.58 | 11.05 | 11.233 | 10.842 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 0 | 54.893 | 39.189 | 49.152 | 24.639 | 25.648 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0.144 | 0 |
| Other Non-Current Liabilities
| 170.587 | 41.341 | 28.605 | 104.157 | 420.989 | 0 |
| Total Non-Current Liabilities
| 170.587 | 96.234 | 67.794 | 153.309 | 445.772 | 25.648 |
| Total Liabilities
| 190.541 | 114.677 | 87.374 | 164.359 | 457.005 | 36.49 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 286.533 | 420.989 | 420.989 |
| Common Stock
| 0.013 | 0.01 | 543.466 | 536.747 | 0.001 | 0.021 |
| Retained Earnings
| -686.015 | -537.314 | -426.538 | -414.573 | -388.096 | -321.572 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | -822.773 | -420.989 | 0 |
| Other Total Stockholders Equity
| 633.333 | 550.85 | 543.456 | 536.737 | 37.778 | 32.763 |
| Total Shareholders Equity
| -52.669 | 13.546 | 116.928 | 122.174 | -350.317 | 132.201 |
| Total Equity
| -52.669 | 13.546 | 116.928 | 122.174 | -350.317 | 132.201 |
| Total Liabilities & Shareholders Equity
| 137.872 | 128.223 | 204.302 | 286.533 | 106.688 | 168.691 |